Singapore Medical Group H1 earnings more than double on demand in diagnostics, aesthetics
THE H1 net profit of Singapore Medical Group 5OT ( : 5OT 0%SMG) more than doubled to S$7.2 million for the half-year period ended June 30, up from S$3.5 million a year ago due to rising demand in the group's aesthetics, Lasik and diagnostic imaging-related services.
The Catalist-listed group said its half-yearly profit was 5.1 per cent higher compared to pre-Covid-19 levels in H1 FY2019.
SMG’s executive director and chief executive officer Beng Teck Liang said that the results came as “a bit of a surprise” and attributed the increased demand for procedures such as health check-ups, plastic surgery and Lasik by…
GET BT IN YOUR INBOX DAILY
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
China knockoff raid jolts a global throng of fake-fashion influencers
Apparel company Express seeks quick bankruptcy sale
Mattel posts narrower loss, thanks to Hot Wheels growth and lower costs
Starbucks set for talks with unionised US stores
Gucci-owner Kering posts 10% drop in Q1 sales on sluggish Chinese demand
China bubble-tea chain Chabaidao plunges on Hong Kong debut